Home > Quotes > ABBV > Company News

AbbVie Inc. News Headlines

ABBV 
$46.26
*  
0.91
  negative  
1.93%
Get ABBV Alerts
*Delayed - data as of May 20, 2013 
Exchange: NYSE
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

AbbVie Begins Phase 3 Study Of Atrasentan
5/20/2013 1:41:00 PM - RTT News

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
5/20/2013 10:32:00 AM - Seeking Alpha

Cramer's Mad Money - 17 Things To Watch In The Week Ahead (5/17/13)
5/20/2013 6:19:00 AM - Seeking Alpha

Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval
5/17/2013 9:07:00 AM - RTT News

Galapagos And AbbVie Extend GLPG0634 Clinical Development Collaboration
5/17/2013 2:41:00 AM - RTT News

Cramer's 6 Stocks in 60 Seconds: RH SWY KORS SCHW NE ABBV (Update 1)
5/15/2013 5:29:00 PM - TheStreet

Mason Hawkins Gives Mickey Mouse the Boot, First Quarter Sells in Review
5/15/2013 11:28:25 AM - GuruFocus

3 Pharmaceuticals For Attractive Dividends
5/15/2013 7:55:00 AM - Seeking Alpha

ABBV Does A Deal, INO Rises, DSCI On A New High, SGEN Gets PDUFA Date
5/14/2013 10:05:00 PM - RTT News

Dodge & Cox Buys Kraft and AbbVie
5/14/2013 6:04:31 PM - GuruFocus

Celgene: Apremilast For Psoriatic Arthritis Offers Upside
5/14/2013 12:50:00 PM - Seeking Alpha

AbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disease
5/14/2013 10:06:00 AM - Dow Jones Business News

AbbVie, Alvine To Collaborate On Investigational Oral Therapy For Celiac Disease
5/14/2013 9:41:00 AM - RTT News

Cramer's Lightning Round - Goodyear Is In The Wilderness (5/13/13)
5/14/2013 7:04:00 AM - Seeking Alpha

AbbVie Chief Scientific Officer John Leonard to Retire
5/10/2013 5:05:00 PM - Dow Jones Business News

Pfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl
5/10/2013 4:52:00 PM - Dow Jones Business News

Dow Closes at New Record High Again Today
5/8/2013 4:28:00 PM - Knobias

Covidien Aiming For Mallinckrodt Spin-Out
5/8/2013 1:54:00 PM - Seeking Alpha

Stocks Modestly Higher at Midday; Dow and S&P Hit New Highs
5/8/2013 1:27:00 PM - Knobias

3 Bio Companies Facing The Patent Cliff
5/7/2013 4:42:00 PM - Seeking Alpha

Merck's Liptruzet Approved in the US - Analyst Blog
5/7/2013 12:22:40 PM - Zacks.com

HRC, MASI Breathe Easy, ABBV Honored, NUVA, SGNT, TBIO Strike Deals
5/6/2013 10:12:00 PM - RTT News

Positive Opinion on Allergan Candidate - Analyst Blog
5/6/2013 5:23:33 PM - Zacks.com

Bayer Discontinues Hemophilia Study - Analyst Blog
5/6/2013 5:23:16 PM - Zacks.com

Good News for Bristol-Myers - Analyst Blog
5/6/2013 4:23:33 PM - Zacks.com